180 related articles for article (PubMed ID: 35092477)
1. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
2. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract][Full Text] [Related]
4. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
[TBL] [Abstract][Full Text] [Related]
5. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the Treatment of Liver Tumors: a Meta-analysis.
Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
[TBL] [Abstract][Full Text] [Related]
6. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis.
Xiong Y; Zhang Y; Hu C
Transl Cancer Res; 2024 Apr; 13(4):1807-1820. PubMed ID: 38737685
[TBL] [Abstract][Full Text] [Related]
8. Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.
Chiang J; Rajendran PS; Hao F; Sayre J; Raman SS; Lu DSK; McWilliams JP
Diagn Interv Radiol; 2023 Nov; 29(6):805-812. PubMed ID: 37665139
[TBL] [Abstract][Full Text] [Related]
9. Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis.
Zhang L; Du F; Zhang Y; Yangdan C; Wang H; Ren L
J Minim Access Surg; 2023; 19(4):453-458. PubMed ID: 37706417
[TBL] [Abstract][Full Text] [Related]
10. Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?
Li Z; Wang C; Si G; Zhou X; Li Y; Li J; Jiao D; Han X
BMC Cancer; 2021 Apr; 21(1):366. PubMed ID: 33827464
[TBL] [Abstract][Full Text] [Related]
11. Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Zensen S; Bücker A; Meetschen M; Haubold J; Opitz M; Theysohn JM; Schramm S; Jochheim L; Kasper S; Forsting M; Schaarschmidt BM
Eur Radiol; 2024 May; 34(5):3322-3330. PubMed ID: 37935847
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.
Hou Q; Wang Y; Zhang D; Luo Y; Dong L; Mu M; Yu J; Liang P
Technol Cancer Res Treat; 2023; 22():15330338231183585. PubMed ID: 38018134
[TBL] [Abstract][Full Text] [Related]
13. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.
Kim HI; An J; Han S; Shim JH
Clin Mol Hepatol; 2023 Oct; 29(4):1013-1028. PubMed ID: 37403319
[TBL] [Abstract][Full Text] [Related]
14. A multicenter case-controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older.
Wang Z; Zhang H; Meng Q; Zhang DZ; Wu SS; Hong ZX; He GB; Yang H; Xiang BD; Li X; Jiang TA; Li K; Tang Z; Huang F; Lu M; Liu C; Yu XL; Cheng ZG; Liu FY; Han ZY; Dou JP; Yu J; Liang P
Int J Surg; 2024 Mar; 110(3):1356-1366. PubMed ID: 38320101
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy.
Tada F; Hiraoka A; Nakatani K; Matsuoka K; Fukumoto M; Matsuda T; Yanagihara E; Saneto H; Murakami T; Onishi K; Izumoto H; Kitahata S; Kanemitsu-Okada K; Kawamura T; Kuroda T; Hanaoka J; Watanabe J; Ohtani H; Yoshida O; Hirooka M; Miyata H; Tsubouchi E; Abe M; Matsuura B; Ninomiya T; Hiasa Y
Clin J Gastroenterol; 2024 Jun; 17(3):401-411. PubMed ID: 38528198
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral perfusion may affect microwave ablation area of hepatocellular carcinoma.
Zhou F; Sun Y; Hou Y; Liu F; Yu X
Int J Hyperthermia; 2023; 40(1):2268892. PubMed ID: 37927295
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies.
Castellana R; Natrella M; Fanelli G; Lancellotta V; Cornacchione P; Castellana M; Filippiadis D; Tagliaferri L; Iezzi R
Eur J Radiol; 2023 Aug; 165():110943. PubMed ID: 37392547
[TBL] [Abstract][Full Text] [Related]
19. Microwave ablation as a primary versus secondary treatment for hepatocellular carcinoma.
Lee P; Makkena A; Tantawi M; Velasquez-Botero F; Eisenbrey JR; Shaw CM
Diagn Interv Radiol; 2023 Mar; 29(2):359-366. PubMed ID: 36988024
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment.
Bai XM; He ZH; Wu H; Yang W; Wang S; Zhang ZY; Wu W; Yan K; Chen MH; Nahum Goldberg S
Eur J Radiol; 2023 Nov; 168():111094. PubMed ID: 37738836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
